CTRC receives crucial NCI Cancer Center designation renewal and gifts from Valero, Klesse Foundations
Announcement of $2 million in major gifts and elite NCI Cancer Center status renewal, accompanied by $9 million in NCI funding over 5 years
11 a.m. Monday, September 29
CTRC, 4th Floor Grossman Building, 7979 Wurzbach Rd., San Antonio,
Ian M. Thompson, Jr., M.D., CTRC Director; William L. Henrich, M.D., MACP, president of the UT Health Science Center; Francisco González-Scarano, M.D., dean of the School of Medicine at the university; Bill Klesse, Chairman, Valero Energy Corporation and the Klesse Foundation
A patient and participant in a CTRC clinical study will also be available for interviews
The Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio is one of the elite academic cancer centers in the country to be named a National Cancer Institute (NCI) Designated Cancer Center, and is one of only four in Texas. A leader in developing new drugs to treat cancer, the CTRC Institute for Drug Development (IDD) conducts one of the largest oncology Phase I clinical drug programs in the world, and participates in development of cancer drugs approved by the U.S. Food & Drug Administration. For more information, visit www.ctrc.net.